Sponsor Led Roundtable: Manufacturing technology landscape of allogenic CGT'
25 Jun 2024
Salon B
Allogeneic
)
- What is the current terminal scale of allogeneic CGT production with respect to total cell numbers and number of doses per lot, and where will it be in 5 years?
- CGT platforms and tools have largely been developed for patient-specific manufacturing; what unit operations are conserved in allogenic manufacturing paradigms that can leverage existing solutions?
- What manufacturing steps in allogenic CGT production lack available solutions that are suitable for the intended purpose?
